Detection of cytoplasmic nucleophosmin expression by imaging flow cytometry

Cytometry Part A

Volumn 81 A, Issue 10, 2012, Pages 896-900

  Grimwade, Lizz ^a   Gudgin, Emma ^b   Bloxham, David ^a   Bottley, Graham ^c   Vassiliou, George ^d   Huntly, Brian ^b   Scott, Mike A ^a   Erber, Wendy N ^a,e  

^a ADDENBROOKE S HOSPITAL   (United Kingdom)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^c Cronus Technologies   (United Kingdom)

^d WELLCOME TRUST SANGER INSTITUTE   (United Kingdom)

^e UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

Author keywords

Acute leukemia; Hematology; Imaging flow cytometry; Nucleophosmin

Indexed keywords

1,5 BIS((2 (METHYLAMINO)ETHYL)AMINO) 4,8 DIHYDROXYANTHRACENE 9,10 DIONE; 1,5-BIS((2-(METHYLAMINO)ETHYL)AMINO)-4,8-DIHYDROXYANTHRACENE-9,10-DIONE; ANTHRAQUINONE DERIVATIVE; ANTIBODY; DIAGNOSTIC AGENT; NUCLEAR PROTEIN; NUCLEOPHOSMIN;

ACUTE GRANULOCYTIC LEUKEMIA; ADULT; AGED; ARTICLE; BONE MARROW; CELL NUCLEUS; CYTOPLASM; FEMALE; FLOW CYTOMETRY; GENE EXPRESSION; GENETICS; HUMAN; MALE; METABOLISM; METHODOLOGY; MIDDLE AGED; MINIMAL RESIDUAL DISEASE; MONONUCLEAR CELL; MUTATION; PATHOLOGY; SENSITIVITY AND SPECIFICITY; STAINING;

ADULT; AGED; AGED, 80 AND OVER; ANTHRAQUINONES; ANTIBODIES; BONE MARROW; CELL NUCLEUS; CYTOPLASM; FEMALE; FLOW CYTOMETRY; GENE EXPRESSION; HUMANS; LEUKEMIA, MYELOID, ACUTE; LEUKOCYTES, MONONUCLEAR; MALE; MIDDLE AGED; MUTATION; NEOPLASM, RESIDUAL; NUCLEAR PROTEINS; RESEARCH DESIGN; SENSITIVITY AND SPECIFICITY; STAINING AND LABELING;

EID: 84866620035     PISSN: 15524922     EISSN: 15524930     Source Type: Journal    
DOI: 10.1002/cyto.a.22116     Document Type: Article

References (14)

1. Cordell J, Pulford K, Bigerna B, Roncador G, Banham A, Colombo E, Pelicci P, Mason D, Falini B. Detection of normal and chimeric nucleophosmin in human cells. Blood 1999; 93: 632-642.
2. Dumbar TS, Gentry GA, Olson MO. Interaction of nucleolar phosphoprotein B23 with nucleic acids. Biochemistry 1989; 28: 9495-9501.
3. Falini B, Mecucci C, Tiacci E, Alcalay M, Rosati R, Pasqualucci L, La Starza R, Diverio D, Colombo E, Santucci A, et al. Cytoplasmic nucleophosmin in acute myelogenous leukemia with a normal karyotype. N Engl J Med 2005; 352: 254-266.
4. Arber D, Brunning R, LeBeau M, Falini B, Vardiman J, Porwit A, Thiele J, Bloomfield C. Acute myeloid leukaemia with recurrent genetic abnormalities. In: Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri S, Stein H, Thiele J, Vardiman JW, editors. WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues, 4th ed. Geneva, Switzerland: IARC Press; 2008; p 110-123.
5. Falini B, Bolli N, Bhan J, Martelli M, Liso A, Pucciarini A, Bigerna B, Pasqualucci L, Mannucci R, Rosati R, et al. Both carboxy-terminus NES motif and mutated tryptophan(s) are crucial for aberrant nuclear export of nucleophosmin leukemic mutants in NPMc+ AML. Blood 2006; 107: 4514-4523.
6. Falini B, Martelli M, Bolli N, Bonasso R, Ghia E, Pallotta M, Diverio D, Nicoletti I, Pacini R, Tabarrini A, et al. Immunohistochemistry predicts nucleophosmin (NPM) mutations in acute myeloid leukemia. Blood 2006; 108: 1999-2005.
7. Mattsson G, Turner SH, Cordell J, Ferguson DJ, Schuh A, Grimwade LF, Bench AJ, Weinberg OK, Marafioti T, George TI, et al. Can cytoplasmic nucleophosmin be detected by immunocytochemical staining of cell smears in acute myeloid leukemia? Haematologica 2010; 95: 670-673.
8. Gruszka AM, Martinelli C, Sparacio E, Pelicci PG, de Marco A. The concurrent use of N- and C-terminal antibodies anti-nucleophosmin 1 in immunofluorescence experiments allows for precise assessment of its subcellular localisation in acute myeloid leukaemia patients. Leukemia 2011; 26: 159-162.
9. Gruszka AM, Lavorgna S, Consalvo MI, Ottone T, Martinelli C, Cinquanta M, Ossolengo G, Pruneri G, Buccisano F, Divona M, et al. A monoclonal antibody against mutated nucleophosmin 1 for the molecular diagnosis of acute myeloid leukemias. Blood 2010; 116: 2096-2102.
10. Oelschlaegel U, Koch S, Mohr B, Schaich M, Falini B, Ehninger G, Thiede C. Rapid flow cytometric detection of aberrant cytoplasmic localization of nucleophosmin (NPMc) indicating mutant NPM1 gene in acute myeloid leukemia. Leukemia 2010; 24: 1813-1816.
11. Grimwade L, Gudgin E, Bloxham D, Scott MA, Erber WN. PML protein analysis using imaging flow cytometry. J Clin Pathol 2011; 64: 447-450.
12. Mirabelli P, Scalia G, Pascariello C, D'Alessio F, Mariotti E, Noto RD, George TC, Kong R, Venkatachalam V, Basiji D, et al. Imagestream promyelocytic leukemia protein immunolocalization: In search of promyelocytic leukemia cells. Cytometry A 2012; 81: 232-237.
13. Tan AY, Westerman DA, Carney DA, Seymour JF, Juneja S, Dobrovic A. Detection of NPM1 exon 12 mutations and FLT3-Internal tandem duplications by high resolution melting analysis in normal karyotype acute myeloid leukemia. J Hematol Oncol 2008; 1: 10.
14. Vassiliou GS, Cooper JL, Rad R, Li J, Rice S, Uren A, Rad L, Ellis P, Andrews R, Banerjee R, et al. Mutant nucleophosmin and cooperating pathways drive leukemia initiation and progression in mice. Nat Genet 2011; 43: 470-475.